Richard Law

Stock Analyst at Goldman Sachs

(2.37)
# 2,532
Out of 4,911 analysts
64
Total ratings
37.93%
Success rate
4.06%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Richard Law

Olema Pharmaceuticals
May 14, 2025
Maintains: Buy
Price Target: $20$18
Current: $4.57
Upside: +293.87%
Silence Therapeutics
May 9, 2025
Maintains: Sell
Price Target: $4$3
Current: $6.28
Upside: -52.23%
Rocket Pharmaceuticals
May 9, 2025
Maintains: Neutral
Price Target: $15$13
Current: $3.21
Upside: +304.98%
Celldex Therapeutics
May 9, 2025
Maintains: Neutral
Price Target: $36$31
Current: $23.22
Upside: +33.51%
Viridian Therapeutics
May 7, 2025
Maintains: Buy
Price Target: $31$27
Current: $17.49
Upside: +54.37%
Viking Therapeutics
Apr 8, 2025
Initiates: Neutral
Price Target: $30
Current: $33.50
Upside: -10.45%
MoonLake Immunotherapeutics
Feb 27, 2025
Maintains: Buy
Price Target: $82$73
Current: $55.03
Upside: +32.65%
Mineralys Therapeutics
Feb 13, 2025
Maintains: Buy
Price Target: $28$24
Current: $14.26
Upside: +68.30%
Merus
Nov 21, 2024
Initiates: Buy
Price Target: $73
Current: $65.69
Upside: +11.13%
Monte Rosa Therapeutics
Aug 11, 2023
Reiterates: Neutral
Price Target: $11
Current: $5.71
Upside: +92.64%
Reiterates: Neutral
Price Target: $31
Current: $11.13
Upside: +178.53%
Maintains: Neutral
Price Target: $46$47
Current: $20.95
Upside: +124.34%
Maintains: Neutral
Price Target: $62$63
Current: $66.06
Upside: -4.63%
Maintains: Neutral
Price Target: $36$37
Current: $45.85
Upside: -19.30%
Reiterates: Outperform
Price Target: $76
Current: $12.78
Upside: +494.68%
Maintains: Neutral
Price Target: $15$14
Current: $3.26
Upside: +329.45%
Reiterates: Outperform
Price Target: $61
Current: $7.89
Upside: +673.13%